Search Results - "GIVEN, B. D"

Refine Results
  1. 1

    Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects by POLONSKY, K. S, GIVEN, B. D, VAN CAUTER, E

    Published in The Journal of clinical investigation (01-02-1988)
    “…The pattern of endogenous insulin secretion over a 24-h period, which included three mixed meals, was evaluated in 14 normal volunteers and 15 obese subjects…”
    Get full text
    Journal Article
  2. 2

    Quantitative study of insulin secretion and clearance in normal and obese subjects by POLONSKY, K. S, GIVEN, B. D, HIRSCH, L, SHAPIRO, E. T, TILLIL, H, BEEBE, C, GALLOWAY, J. A, FRANK, B. H, KARRISON, T, VAN CAUTER, E

    Published in The Journal of clinical investigation (01-02-1988)
    “…The secretion and hepatic extraction of insulin were compared in 14 normal volunteers and 15 obese subjects using a previously validated mathematical model of…”
    Get full text
    Journal Article
  3. 3

    Use of biosynthetic human-C peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients by POLONSKY, K. S, LICINIO-PAIXAO, J, GIVEN, B. D, PUGH, W, RUE, P, GALLOWAY, J, KARRISON, T, FRANK, B

    “…We undertook this study to examine the accuracy of plasma C-peptide as a marker of insulin secretion. The peripheral kinetics of biosynthetic human C-peptide…”
    Get full text
    Journal Article
  4. 4

    Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus by Polonsky, K S, Given, B D, Hirsch, L J, Tillil, H, Shapiro, E T, Beebe, C, Frank, B H, Galloway, J A, Van Cauter, E

    Published in The New England journal of medicine (12-05-1988)
    “…To determine whether non-insulin-dependent diabetes is associated with specific alterations in the pattern of insulin secretion, we studied 16 patients with…”
    Get more information
    Journal Article
  5. 5

    Diabetes due to secretion of a structurally abnormal insulin (insulin Wakayama): clinical and functional characteristics of [LeuA3] insulin by NANJO, K, SANKE, T, CHAN, S. J, TAGER, H. S, STEINER, D. F, RUBENSTEIN, A. H, MIYANO, M, OKAI, K, SOWA, R, KONDO, M, NISHIMURA, S, IWO, K, MIYAMURA, K, GIVEN, B. D

    Published in The Journal of clinical investigation (01-02-1986)
    “…We have identified a non-insulin-dependent diabetic patient with fasting hyperinsulinemia (90 microU/ml), an elevated insulin:C-peptide molar ratio (1.68;…”
    Get full text
    Journal Article
  6. 6

    Biochemical and clinical implications of proinsulin conversion intermediates by GIVEN, B. D, COHEN, R. M, SHOELSON, S. E, FRANK, B. H, RUBENSTEIN, A. H, TAGER, H. S

    Published in The Journal of clinical investigation (01-10-1985)
    “…Since a complete map of insulin-related peptides in humans requires consideration of proinsulin, Arg32/Glu33-split proinsulin, Arg65/Gly66-split proinsulin,…”
    Get full text
    Journal Article
  7. 7

    Hypoglycemia due to surreptitious injection of insulin. Identification of insulin species by high-performance liquid chromatography by B D Given, D M Ostrega, K S Polonsky, D Baldwin, Jr, R I Kelley, A H Rubenstein

    Published in Diabetes care (01-07-1991)
    “…Hypoglycemia due to surreptitious injection of insulin. Identification of insulin species by high-performance liquid chromatography. B D Given , D M Ostrega ,…”
    Get full text
    Journal Article
  8. 8

    Ingestion of a mixed meal does not affect the metabolic clearance rate of biosynthetic human C-peptide by Licinio-Paixao, J, Polonsky, K S, Given, B D, Pugh, W, Ostrega, D, Frank, B F, Rubenstein, A H

    “…The validity of C-peptide as a peripheral marker of insulin secretion during different physiological conditions depends on the demonstration that C-peptide…”
    Get more information
    Journal Article
  9. 9

    Glyburide enhances the responsiveness of the beta-cell to glucose but does not correct the abnormal patterns of insulin secretion in noninsulin-dependent diabetes mellitus by Shapiro, E T, Van Cauter, E, Tillil, H, Given, B D, Hirsch, L, Beebe, C, Rubenstein, A H, Polonsky, K S

    “…Eleven patients with noninsulin-dependent diabetes mellitus were studied before and after 6-10 weeks of glyburide therapy. Patients were studied during a 24-h…”
    Get more information
    Journal Article
  10. 10

    Reevaluation of urine C-peptide as measure of insulin secretion by TILLIL, H, SHAPIRO, E. T, GIVEN, B. D, RUE, P, RUBENSTEIN, A. H, GALLOWAY, J. A, POLONSKY, K. S

    Published in Diabetes (New York, N.Y.) (01-09-1988)
    “…Urine C-peptide (UCP) has been proposed as a measure of insulin secretion, because insulin and C-peptide are consecreted in equimolar concentrations by the…”
    Get full text
    Journal Article
  11. 11

    Insulin Wakayama: familial mutant insulin syndrome in Japan by NANJO, K, MIYANO, M, TAGER, H. S, STEINER, D. F, RUBENSTEIN, A. H, KONDO, M, SANKE, T, NISHIMURA, S, MIYAMURA, K, INOUYE, K, GIVEN, B. D, CHAN, S. J, POLONSKY, K. S

    Published in Diabetologia (01-02-1987)
    “…We describe a family from Japan displaying the mutant insulin syndrome with hyperinsulinaemia and an increased insulin: C-peptide molar ratio. Serum insulin…”
    Get full text
    Journal Article
  12. 12

    Calculation of the systemic delivery rate of insulin in normal man by Polonsky, K S, Given, B D, Pugh, W, Licinio-Paixao, J, Thompson, J E, Karrison, T, Rubenstein, A H

    “…The accuracy with which the systemic delivery rate of insulin can be estimated from peripheral insulin concentrations was investigated in eight normal men…”
    Get more information
    Journal Article
  13. 13

    Change in hexose distribution volume and fractional utilization of [18F]-2-deoxy-2-fluoro-D-glucose in brain during acute hypoglycemia in humans by Shapiro, E. T., Cooper, M., Chen, C. T., Given, B. D., Polonsky, K. S.

    Published in Diabetes (New York, N.Y.) (01-02-1990)
    “…Change in hexose distribution volume and fractional utilization of [18F]-2-deoxy-2-fluoro-D-glucose in brain during acute hypoglycemia in humans. E T Shapiro ,…”
    Get full text
    Journal Article
  14. 14

    Reevaluation of urine C-peptide as measure of insulin secretion by Tillil, H., Shapiro, E. T., Given, B. D., Rue, P., Rubenstein, A. H., Galloway, J. A., Polonsky, K. S.

    Published in Diabetes (New York, N.Y.) (01-09-1988)
    “…Reevaluation of urine C-peptide as measure of insulin secretion. H Tillil , E T Shapiro , B D Given , P Rue , A H Rubenstein , J A Galloway and K S Polonsky…”
    Get full text
    Journal Article
  15. 15

    Pharmacokinetics and pharmacodynamics of dilevalol by Tenero, D M, Bottorff, M B, Given, B D, Kramer, W G, Affrime, M B, Patrick, J E, Lalonde, R L

    Published in Clinical pharmacology and therapeutics (01-12-1989)
    “…The pharmacokinetics and pharmacodynamics of dilevalol, the R,R stereoisomer of labetalol, were evaluated in nine subjects. Dilevalol was given as a single 50…”
    Get more information
    Journal Article
  16. 16

    Duration of action and short-term hormonal responses to enalapril (MK 421) in normal subjects by Given, B D, Taylor, T, Hollenberg, N K, Williams, G H

    Published in Journal of cardiovascular pharmacology (01-05-1984)
    “…Enalapril is a converting enzyme inhibitor with a prolonged duration of action. We investigated the arterial pressure and hormonal responses to angiotensin I…”
    Get more information
    Journal Article
  17. 17
  18. 18
  19. 19

    Severe hypoglycemia attributable to surreptitious injection of insulin in a mare by Given, B D, Mostrom, M S, Tully, R, Ditkowsky, N, Rubenstein, A H

    “…A mare with signs of hypoglycemia had high serum insulin concentrations before it was euthanatized. High pressure liquid chromatography revealed that the…”
    Get more information
    Journal Article
  20. 20

    Prostaglandin E2 analogue elicits renal and hormonal compensatory mechanisms in human hypertension by Given, B D, Vita, N A, Black, H R, Francis, C, Lasseter, K, Morray, R L, Mickiewicz, C, Akester, J, Koury, K, Dzau, V J

    Published in Hypertension (Dallas, Tex. 1979) (01-06-1986)
    “…Endogenous prostaglandin E2 appears to play an important role in cardiovascular homeostasis. When administered exogenously, it is a potent vasodilator, but the…”
    Get full text
    Journal Article